89bio, Inc. (ETNB)
NASDAQ
Market Cap
$938.3M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
27 of 966
Rank in Industry
22 of 554
Largest Insider Buys in Sector
ETNB Stock Price History Chart
ETNB Stock Performance
About 89bio, Inc.
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.
Insider Activity of 89bio, Inc.
Over the last 12 months, insiders at 89bio, Inc. have bought $20.89M and sold $1.41M worth of 89bio, Inc. stock.
On average, over the past 5 years, insiders at 89bio, Inc. have bought $37.98M and sold $4.53M worth of stock each year.
Highest buying activity among insiders over the last 12 months: RA CAPITAL MANAGEMENT, L.P. () — $621.67M. PALEKAR ROHAN (Chief Executive Officer) — $83,500. McWherter Charles (director) — $80,000.
The last purchase of 10,000 shares for transaction amount of $80,000 was made by McWherter Charles (director) on 2024‑12‑05.
List of Insider Buy and Sell Transactions, 89bio, Inc.
| 2024-12-05 | director | 10,000 0.0086% | $8.00 | $80,000 | +2.28% | |||
| 2024-11-22 | Chief Executive Officer | 10,000 0.0081% | $8.35 | $83,500 | +1.60% | |||
| 2024-10-30 | Sale | See Remarks | 27,955 0.0268% | $8.12 | $226,995 | +11.83% | ||
| 2024-04-01 | Sale | Chief Executive Officer | 52,718 0.0573% | $10.91 | $575,153 | -20.04% | ||
| 2024-03-04 | 1.35M 1.6718% | $15.35 | $20.72M | -36.47% | ||||
| 2024-02-26 | Sale | Chief Executive Officer | 4,477 0.0047% | $10.76 | $48,173 | -20.40% | ||
| 2023-12-29 | Sale | Chief Executive Officer | 50,000 0.0549% | $11.20 | $560,000 | -20.05% | ||
| 2023-07-17 | Sale | director | 12,500 0.024% | $18.80 | $235,000 | -43.21% | ||
| 2023-06-05 | Sale | Chief Executive Officer | 15,000 0.0282% | $20.00 | $300,000 | -44.75% | ||
| 2023-06-01 | Sale | director | 6,250 0.0112% | $17.91 | $111,938 | -41.25% | ||
| 2023-05-09 | Sale | See Remarks | 13,683 0.0258% | $18.11 | $247,799 | -36.64% | ||
| 2023-04-04 | Sale | Chief Financial Officer | 8,721 0.0165% | $14.95 | $130,379 | -2.87% | ||
| 2023-03-28 | director | 61,538 0.112% | $16.15 | $993,839 | -11.14% | |||
| 2023-03-24 | 2.46M 4.6238% | $16.25 | $40M | -7.38% | ||||
| 2023-03-23 | Sale | Chief Executive Officer | 15,000 0.0266% | $16.00 | $240,000 | -10.98% | ||
| 2023-03-23 | Sale | Chief Financial Officer | 5,000 0.0089% | $16.11 | $80,550 | -10.98% | ||
| 2023-03-01 | Sale | director | 10,000 0.0184% | $13.60 | $136,000 | +8.33% | ||
| 2023-02-21 | Sale | Chief Financial Officer | 2,540 0.0048% | $13.89 | $35,281 | +8.71% | ||
| 2023-02-08 | Sale | Chief Financial Officer | 1,480 0.0027% | $14.41 | $21,327 | +3.28% | ||
| 2023-02-03 | Sale | Chief Financial Officer | 3,592 0.0067% | $13.04 | $46,848 | +14.12% |
Insider Historical Profitability
35.01%
| RA CAPITAL MANAGEMENT, L.P. | 12431584 10.5727% | $7.98 | 10 | 0 | <0.0001% | |
| PALEKAR ROHAN | Chief Executive Officer | 466236 0.3965% | $7.98 | 5 | 5 | <0.0001% |
| Le-Nguyen Quoc | See Remarks | 187796 0.1597% | $7.98 | 0 | 3 | |
| McWherter Charles | director | 10000 0.0085% | $7.98 | 1 | 0 | |
| Shah Rajeev M. | 7782669 6.6189% | $7.98 | 1 | 0 | +239.97% | |
| Longitude Capital Partners III, LLC | 10 percent owner | 2600877 2.212% | $7.98 | 2 | 0 | +2.62% |
| Naschitz Anat | 1864721 1.5859% | $7.98 | 1 | 1 | +28.8% | |
| ORBIMED ADVISORS LLC | 10 percent owner | 1829433 1.5559% | $7.98 | 1 | 3 | +28.8% |
| Kariv Tomer | 250000 0.2126% | $7.98 | 1 | 0 | +28.8% | |
| Hayden Michael R | director | 61538 0.0523% | $7.98 | 8 | 0 | +100.2% |
| Martins Ryan | Chief Financial Officer | 53578 0.0456% | $7.98 | 0 | 7 | |
| LAPORTE KATHLEEN | director | 0 0% | $7.98 | 0 | 1 | |
| Grunberg Gregory | director | 0 0% | $7.98 | 2 | 1 | +2.62% |
| Waisbourd Ram | See Remarks | 0 0% | $7.98 | 0 | 15 | |
| Atkinson Edward Morrow III | director | 0 0% | $7.98 | 0 | 2 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| RA Capital Management, L.P. | $148.61M | 12.98 | 12.77M | +11.82% | +$15.71M | 0.15 | |
| Janus Henderson | $146.65M | 12.81 | 12.6M | +41.37% | +$42.91M | 0.07 | |
| RTW Investments, LP | $85.89M | 7.5 | 7.38M | +32.26% | +$20.95M | 1.29 | |
| BlackRock | $77.27M | 6.75 | 6.64M | +21.7% | +$13.78M | <0.01 | |
| Suvretta Capital Management, LLC | $73.31M | 6.4 | 6.3M | +28.84% | +$16.41M | 3.1 | |
| State Street | $64.53M | 5.64 | 5.54M | +2.67% | +$1.68M | <0.01 | |
| The Vanguard Group | $54.98M | 4.8 | 4.72M | +9.64% | +$4.84M | <0.01 | |
| Bvf Inc Il | $47.11M | 4.11 | 4.05M | 0% | +$0 | 0.35 | |
| Holocene Advisors, LP | $40.17M | 3.51 | 3.45M | -1.14% | -$464,889.96 | 0.15 | |
| Laurion Capital Management LP | $31.42M | 2.74 | 2.7M | -0.17% | -$55,080.48 | 0.22 | |
| Redmile Group | $26.36M | 2.3 | 2.26M | +14.99% | +$3.44M | 0.27 | |
| Westfield Capital Management Co Lp | $25.19M | 2.2 | 2.16M | +22.88% | +$4.69M | 0.13 | |
| Geode Capital Management | $20.27M | 1.77 | 1.74M | +26.36% | +$4.23M | <0.01 | |
| Citadel Advisors LLC | $18.27M | 1.6 | 1.57M | -27.95% | -$7.09M | 0.01 | |
| Millennium Management LLC | $12.65M | 1.11 | 1.09M | +94.53% | +$6.15M | 0.01 | |
| Frazier Life Sciences Management L P | $11.64M | 1.02 | 1M | -50% | -$11.64M | 0.53 | |
| Bioimpact Capital Llc | $11.26M | 0.98 | 967,742 | New | +$11.26M | 1.82 | |
| Franklin Templeton Investments | $9.63M | 0.84 | 827,657 | <0.01% | -$535.44 | <0.01 | |
| Morgan Stanley | $9.46M | 0.83 | 812,622 | -45.44% | -$7.88M | <0.01 | |
| Orchard Capital Managment Llc | $8.72M | 0.76 | 749,350 | +1.37% | +$118,052.88 | 2.56 | |
| Goldman Sachs | $8.67M | 0.76 | 744,948 | +18.04% | +$1.33M | <0.01 | |
| Northern Trust | $8.32M | 0.73 | 714,531 | +15.62% | +$1.12M | <0.01 | |
| HERITAGE ASSET MANAGEMENT INC | $7.29M | 0.69 | 679,767 | -3.18% | -$239,579.41 | 0.04 | |
| Charles Schwab | $7.32M | 0.64 | 629,233 | +26.01% | +$1.51M | <0.01 | |
| Nuveen | $6.41M | 0.56 | 550,594 | +127.15% | +$3.59M | <0.01 | |
| Sphera Fund | $6M | 0.52 | 515,882 | +26.23% | +$1.25M | 0.04 | |
| Standard Life | $5.48M | 0.48 | 470,387 | +119.61% | +$2.98M | 0.01 | |
| Rafferty Asset Management Llc | $5.38M | 0.47 | 461,952 | +1.82% | +$96,355.91 | 0.02 | |
| Adage Capital Partners Gp L L C | $5.24M | 0.46 | 450,000 | -85.6% | -$31.14M | 0.01 | |
| Citigroup | $4.87M | 0.43 | 418,259 | +94.9% | +$2.37M | <0.01 | |
| Bank of America | $4.76M | 0.42 | 408,639 | +50.29% | +$1.59M | <0.0001 | |
| Barclays | $4.12M | 0.36 | 354,088 | -34.86% | -$2.21M | <0.01 | |
| UBS | $3.73M | 0.33 | 320,732 | +12.74% | +$421,775.35 | <0.01 | |
| Candriam S C A | $3.61M | 0.32 | 310,000 | +10.71% | +$349,200.00 | 0.02 | |
| Wellington Management Company | $3.58M | 0.31 | 307,924 | +28.82% | +$801,961.22 | <0.01 | |
| Alyeska Investment Group L P | $3.49M | 0.31 | 300,000 | -48.56% | -$3.3M | 0.02 | |
| Integral Health Asset Management Llc | $3.49M | 0.31 | 300,000 | New | +$3.49M | 0.35 | |
| Newtyn Management | $2.91M | 0.25 | 250,000 | -8.26% | -$261,900.00 | 0.64 | |
| BNY Mellon | $2.9M | 0.25 | 248,746 | +11.84% | +$306,434.59 | <0.01 | |
| Two Sigma | $2.86M | 0.25 | 246,100 | +91.13% | +$1.37M | <0.01 | |
| AllianceBernstein | $2.69M | 0.24 | 231,007 | -22.74% | -$791,310.34 | <0.01 | |
| Parkman Healthcare Partners Llc | $2.09M | 0.18 | 179,899 | -18.02% | -$460,350.28 | 0.26 | |
| Susquehanna International Group | $2.09M | 0.18 | 179,962 | +8.27% | +$160,073.30 | <0.01 | |
| Comerica | $1.99M | 0.17 | 171,000 | +9.66% | +$175,414.80 | 0.01 | |
| Swiss National Bank | $1.71M | 0.15 | 147,200 | +3.08% | +$51,216.00 | <0.01 | |
| Two Sigma Advisers LP | $1.67M | 0.15 | 143,500 | -14.23% | -$277,032.00 | <0.01 | |
| Caption Management Llc | $1.64M | 0.14 | 140,984 | -45.77% | -$1.39M | 0.05 | |
| Raymond James Associates | $1.57M | 0.14 | 135,273 | +24.79% | +$312,766.86 | <0.01 | |
| Schonfeld Group | $1.56M | 0.14 | 134,054 | +72.4% | +$655,285.20 | 0.01 | |
| Royal Bank of Canada | $1.53M | 0.13 | 130,996 | -47.38% | -$1.37M | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.